Fixed drug eruption from atezolizumab

We present a 48-year-old woman with FDE being treated for metastatic breast cancer with atezolizumab. We believe this is the first reported case of FDE secondary to atezolizumab.
Source: Dermatology Online Journal - Category: Dermatology Source Type: research